Olympus (OCPNY) Stock Price, News & Analysis

Company Overview

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company's medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications. Olympus emphasizes research and development, regulatory compliance and post-sale support, providing training, maintenance and repair services alongside its product portfolio. Its offerings address a range of clinical specialties and laboratory needs, reflecting a shift toward recurring revenue streams tied to consumables, procedures and service contracts.

Olympus operates globally through regional subsidiaries and distribution networks across Japan, the Americas, Europe and Asia-Pacific, serving hospitals, research institutions and industrial customers worldwide. The company is managed from its Tokyo headquarters and maintains manufacturing, R&D and service operations in multiple countries to support product development and local market requirements. Olympus's business orientation positions it as a specialist provider of imaging and diagnostic tools rather than a consumer electronics brand.

Key Stats

• Today's Range: $18.00 to $18.00
• 50-Day Range: $18.00 to $18.00
• 52-Week Range: $16.80 to $74.99
• Volume: 400 shs
• Average Volume: 860,265 shs
• Market Capitalization: $23.15 billion
• P/E Ratio: 21.95
• Dividend Yield: 0.44%
• Price Target: N/A
• Consensus Rating: Buy

Olympus Stock Analysis - MarketRank™

Olympus scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.7 / 5
• Analyst Rating: Buy

Consensus Rating

Olympus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Olympus has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -47.27%

Earnings Growth

Earnings for Olympus are expected to decrease by -47.27% in the coming year, from $1.65 to $0.87 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Olympus is 21.95, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 42.78.

Price to Earnings Ratio vs. Sector

The P/E ratio of Olympus is 21.95, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 17.54.

Price to Earnings Growth Ratio

Olympus has a PEG Ratio of 1.07. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Olympus has a P/B Ratio of 5.14. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for OCPNY.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Olympus has a dividend yield of 0.43%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Olympus does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Olympus is 9.76%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Olympus will have a dividend payout ratio of 9.20% next year. This indicates that Olympus will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Olympus this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Olympus insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.03% of the stock of Olympus is held by institutions.

Company Calendar

• Last Earnings: 8/05/2021
• Today: 5/19/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Structural clay products
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:OCPNY
• CIK: N/A
• Web: www.olympus-global.com
• Phone: (133) 340-2111
• Fax: 813-3340-2062
• Employees: 31,557
• Year Founded: 1919

Profitability

• EPS (Trailing Twelve Months): $0.82
• Trailing P/E Ratio: 21.95
• Forward P/E Ratio: 10.91
• P/E Growth: 1.07
• Net Income: $1.03 billion
• Net Margins: 13.80%
• Pretax Margin: N/A
• Return on Equity: 24.30%
• Return on Assets: 9.30%

Debt

• Debt-to-Equity Ratio: 0.59
• Current Ratio: 1.99
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $7.74 billion
• Price / Sales: 2.99
• Cash Flow: $1.22 per share
• Price / Cash Flow: 14.76
• Book Value: $3.50 per share
• Price / Book: 5.14

Miscellaneous

• Outstanding Shares: 1,285,890,000
• Free Float: N/A
• Market Cap: $23.15 billion
• Optionable: Not Optionable
• Beta: 0.70